Next-Generation Platforms
Genome- and Transcriptome-Wide Mapping of Alternative Nucleic Acids
We provide the only platforms engineered to map alternative nucleic acid structures that conventional static assays miss, accelerating target validation.
Drug Development
Pharmaceutical Epitranscriptomics for Cancer Immunotherapy (PETCI) is a therapeutic concept aimed at harnessing RNA-editing mechanisms to selectively activate antiviral innate immune responses in tumor cells.
Beyond Mapping
Harnessing the RNA Dynamics to Activate Innate Immunity
Dynoma Biosciences is developing a new class of Z-conformation–stabilizing small molecules designed to stabilize Z-RNA and harness its immunological potential for cancer therapy.
Accelerate Your Drug Discovery Pipeline
Request technical specifications or schedule a platform demonstration to see how Dynoma can unlock novel therapeutic targets with unprecedented mechanistic resolution.